You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 8, February 25, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Psychiatry
 •Adverse Effects
 •Alert me on articles by topic

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Bowden and Fawcett point out the many potential sources of bias or confounding in our comparison of lithium and divalproex. We did in fact measure and adjust for comorbid substance abuse and anxiety disorder, but we lacked data on many other potential risk factors. This is an inevitable shortcoming of large epidemiologic studies based on administrative claims data. Our analyses do indicate that 1 year of treatment was a far stronger predictor of drug choice than any clinical characteristics of individual patients, arguing against significant confounding by indication.

Bowden and Fawcett are also concerned about our comparison of lithium treatment with periods of no treatment. Our data actually show slightly higher risk of serious attempt or suicide death during times without mood stabilizer treatment (bottom rows of Table 2). As we pointed out, however, this comparison is much more subject to bias than is the comparison of . . . [Full Text of this Article]

Frederick K. Goodwin, MD
fgoodwin@mfa.gwu.edu
Department of Psychiatry
George Washington University Medical Center
Washington, DC

Greg Simon, MD
Center for Health Studies
Group Health Cooperative
Seattle, Wash

Dennis Revicki, PhD
MEDTAP International
Bethesda, Md

Enid Hunkeler, MA; Bruce Fireman, MA; Janelle Lee, MHA, DrPH
Division of Research
Kaiser Permanente Medical Care Program
Oakland, Calif


RELATED ARTICLES

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
Charles Bowden and Jan Fawcett
JAMA. 2004;291(8):939.
EXTRACT | FULL TEXT  

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
Boghos I. Yerevanian, Ralph J. Koek, and Jamie D. Feusner
JAMA. 2004;291(8):939.
EXTRACT | FULL TEXT  

Suicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex
Frederick K. Goodwin, Bruce Fireman, Gregory E. Simon, Enid M. Hunkeler, Janelle Lee, and Dennis Revicki
JAMA. 2003;290(11):1467-1473.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.